Insider Trading History of Kirk Randal J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kirk Randal J since year 2005. The trader's CIK number is 1091823. At the time of the last reporting, Kirk Randal J was the Officer of Aquabounty Technologies, Inc. . (stock ticker symbol AQB). See this page for all insider trading activities at Aquabounty Technologies, Inc. .

Note that in the past KIRK RANDAL J also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Kirk Randal J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2020-02-13 AQB Aquabounty Technologies, Inc. Buy 5,175,000 1.50 7,762,500
2020-01-31 PGEN Precigen, Inc. Buy 5,972,696 5.86 34,999,998
2020-01-04 XON Precigen, Inc. Option Ex 3,443 .00 0
2019-06-07 XON Precigen, Inc. Buy 148,237 5.26 779,726
2019-06-06 XON Precigen, Inc. Buy 260,913 5.23 1,364,574
2019-06-07 XON Precigen, Inc. Buy 222,355 5.26 1,169,587
2019-06-06 XON Precigen, Inc. Buy 173,942 5.23 909,716
2019-05-31 XON Precigen, Inc. Buy 135,642 4.78 648,368
2019-06-04 XON Precigen, Inc. Buy 67,679 5.17 349,900
2019-06-04 XON Precigen, Inc. Buy 45,120 5.17 233,270
2019-05-31 XON Precigen, Inc. Buy 90,428 4.78 432,245
2019-05-30 XON Precigen, Inc. Buy 307,592 4.79 1,473,365
2019-05-29 XON Precigen, Inc. Buy 187,679 4.68 878,337
2019-05-30 XON Precigen, Inc. Buy 205,060 4.79 982,237
2019-05-29 XON Precigen, Inc. Buy 125,120 4.68 585,561
2019-05-23 XON Precigen, Inc. Buy 85,750 4.67 400,452
2019-05-24 XON Precigen, Inc. Buy 108,645 4.68 508,458
2019-05-23 XON Precigen, Inc. Buy 128,626 4.67 600,683
2019-05-22 XON Precigen, Inc. Buy 172,779 4.70 812,061
2019-05-24 XON Precigen, Inc. Buy 72,430 4.68 338,972
2019-05-22 XON Precigen, Inc. Buy 115,187 4.70 541,378
2019-05-17 XON Precigen, Inc. Buy 60,530 4.69 283,885
2019-05-21 XON Precigen, Inc. Buy 60,223 4.74 285,457
2019-05-20 XON Precigen, Inc. Buy 301,670 4.63 1,396,732
2019-05-17 XON Precigen, Inc. Buy 90,794 4.69 425,823
2019-05-21 XON Precigen, Inc. Buy 90,335 4.74 428,187
2019-05-20 XON Precigen, Inc. Buy 452,502 4.63 2,095,084
2019-05-15 XON Precigen, Inc. Buy 314,050 4.59 1,441,489
2019-05-14 XON Precigen, Inc. Buy 147,500 4.37 644,575
2019-05-13 XON Precigen, Inc. Buy 376,932 4.25 1,601,961
2019-05-15 XON Precigen, Inc. Buy 471,077 4.59 2,162,243
2019-05-14 XON Precigen, Inc. Buy 221,251 4.37 966,866
2019-05-13 XON Precigen, Inc. Buy 565,399 4.25 2,402,945
2018-08-28 PRPO Precipio, Inc. Sale 24,600 .41 10,086
2018-08-28 HALO Halozyme Therapeutics, Inc. Sale 432,249 18.02 7,789,126
2018-08-27 HALO Halozyme Therapeutics, Inc. Sale 109,377 18.22 1,992,848
2018-08-24 HALO Halozyme Therapeutics, Inc. Sale 103,372 18.20 1,881,370
2018-08-21 HALO Halozyme Therapeutics, Inc. Sale 161,246 17.15 2,765,368
2018-08-22 HALO Halozyme Therapeutics, Inc. Sale 781,881 17.49 13,675,098
2018-08-23 HALO Halozyme Therapeutics, Inc. Sale 251,335 18.48 4,644,670
2018-08-16 HALO Halozyme Therapeutics, Inc. Sale 95,363 17.24 1,644,058
2018-08-15 HALO Halozyme Therapeutics, Inc. Sale 91,541 17.15 1,569,928
2018-08-14 HALO Halozyme Therapeutics, Inc. Sale 303,168 17.36 5,262,996
2018-08-08 HALO Halozyme Therapeutics, Inc. Sale 146,718 17.52 2,570,499
2018-08-09 HALO Halozyme Therapeutics, Inc. Sale 223,127 17.48 3,900,259
2018-08-10 HALO Halozyme Therapeutics, Inc. Sale 202,959 17.08 3,466,539
2018-07-27 HALO Halozyme Therapeutics, Inc. Sale 48,927 16.90 826,866
2018-07-26 HALO Halozyme Therapeutics, Inc. Sale 150,000 17.30 2,595,000
2018-07-25 HALO Halozyme Therapeutics, Inc. Sale 103,900 17.32 1,799,548
2018-07-03 XON Precigen, Inc. Buy 7,479,431 13.37 99,999,992
2018-06-27 HALO Halozyme Therapeutics, Inc. Sale 53,505 17.34 927,776
2018-06-28 HALO Halozyme Therapeutics, Inc. Sale 128,385 16.99 2,181,261
2018-06-29 HALO Halozyme Therapeutics, Inc. Sale 122,431 16.97 2,077,654
2018-01-19 XON Precigen, Inc. Buy 1,000,000 12.50 12,500,000
2017-08-11 XON Precigen, Inc. Buy 132,625 18.85 2,499,981
2017-06-08 TBIO Precipio, Inc. Sale 1,975,000 1.00 1,975,000
2017-05-11 HALO Halozyme Therapeutics, Inc. Option Ex 10,000 10.37 103,699
2016-12-13 XON Precigen, Inc. Buy 34,606 28.90 1,000,113
2016-05-13 XON Precigen, Inc. Buy 41,830 23.92 1,000,573
2016-01-06 TBIO Precipio, Inc. Buy 4,474,825 1.00 4,474,825
2015-12-11 XON Precigen, Inc. Buy 124,475 29.84 3,714,956
2015-12-07 XON Precigen, Inc. Buy 237,525 30.69 7,289,642
2015-01-27 XON Precigen, Inc. Buy 555,556 27.00 15,000,012
2014-05-13 XON Precigen, Inc. Buy 32,019 15.63 500,456
2014-05-12 XON Precigen, Inc. Buy 18,066 15.89 287,068
2014-05-09 XON Precigen, Inc. Buy 15,088 13.42 202,480
2014-03-27 XON Precigen, Inc. Buy 243,001 25.72 6,249,985
2013-08-13 XON Precigen, Inc. Buy 1,887,500 16.00 30,200,000
2013-01-25 TBIO.OB Precipio, Inc. Buy 6,000,000 .00 0
2012-06-01 HALO Halozyme Therapeutics, Inc. Buy 99,080 7.39 732,201
2012-06-04 HALO Halozyme Therapeutics, Inc. Buy 89,646 7.37 660,691
2012-06-05 HALO Halozyme Therapeutics, Inc. Buy 5,463 7.48 40,863
2012-05-15 HALO Halozyme Therapeutics, Inc. Buy 427,581 7.35 3,142,720
2012-05-16 HALO Halozyme Therapeutics, Inc. Buy 344,910 7.44 2,566,130
2012-05-17 HALO Halozyme Therapeutics, Inc. Buy 299,007 7.50 2,242,552
2012-02-10 HALO Halozyme Therapeutics, Inc. Buy 1,360,000 10.61 14,429,600
2011-11-21 HALO Halozyme Therapeutics, Inc. Buy 56,477 8.04 454,075
2011-11-22 HALO Halozyme Therapeutics, Inc. Buy 55,146 8.11 447,234
2011-11-23 HALO Halozyme Therapeutics, Inc. Buy 166,100 8.00 1,328,800
2011-11-16 HALO Halozyme Therapeutics, Inc. Buy 175,520 8.19 1,437,508
2011-11-15 HALO Halozyme Therapeutics, Inc. Buy 242,704 8.18 1,985,318
2011-11-14 HALO Halozyme Therapeutics, Inc. Buy 220,000 8.13 1,788,600
2011-08-09 HALO Halozyme Therapeutics, Inc. Buy 738,331 5.88 4,341,386
2011-08-10 HALO Halozyme Therapeutics, Inc. Buy 261,669 6.13 1,604,030
2008-06-23 HALO Halozyme Therapeutics, Inc. Buy 713,232 5.71 4,072,554
2008-06-23 HALO Halozyme Therapeutics, Inc. Buy 28,463 5.54 157,571
2008-06-19 HALO Halozyme Therapeutics, Inc. Buy 59,900 6.02 360,598
2008-06-20 HALO Halozyme Therapeutics, Inc. Buy 175,500 5.85 1,026,674
2008-06-20 CLDA Clinical Data Inc Buy 5,985 16.49 98,692
2008-06-11 HALO Halozyme Therapeutics, Inc. Buy 115,439 5.27 608,363
2008-06-13 HALO Halozyme Therapeutics, Inc. Buy 45,725 5.53 252,859
2008-06-12 HALO Halozyme Therapeutics, Inc. Buy 57,000 5.42 308,940
2008-03-20 HALO Halozyme Therapeutics, Inc. Buy 1,264,657 6.09 7,701,761
2008-03-18 HALO Halozyme Therapeutics, Inc. Buy 207,546 4.57 948,485
2008-03-19 HALO Halozyme Therapeutics, Inc. Buy 886,650 5.80 5,142,570
2008-03-18 HALO Halozyme Therapeutics, Inc. Buy 207,546 4.57 948,485
2008-03-19 HALO Halozyme Therapeutics, Inc. Buy 886,650 5.80 5,142,570
2007-09-18 HALO Halozyme Therapeutics, Inc. Buy 15,489 8.87 137,387
2007-09-19 HALO Halozyme Therapeutics, Inc. Buy 23,085 9.00 207,765
2007-09-17 HTI Halozyme Therapeutics, Inc. Buy 238,020 8.66 2,061,253
2007-09-14 HTI Halozyme Therapeutics, Inc. Buy 127,693 8.71 1,112,206
2007-09-13 HTI Halozyme Therapeutics, Inc. Buy 65,713 8.74 574,331
2007-07-17 CLDA Clinical Data Inc Buy 2,250,000 22.00 49,500,000
2007-05-30 HTI Halozyme Therapeutics, Inc. Buy 3,500,000 9.17 32,095,000
2007-03-13 HTI Halozyme Therapeutics, Inc. Buy 46,080 7.93 365,414
2007-03-14 HTI Halozyme Therapeutics, Inc. Buy 30,200 7.91 238,882
2006-12-11 HTI Halozyme Therapeutics, Inc. Buy 80,000 6.16 492,800
2006-12-07 HTI Halozyme Therapeutics, Inc. Buy 336,200 5.55 1,865,910
2006-12-04 HTI Halozyme Therapeutics, Inc. Buy 11,500 2.86 32,890
2006-12-05 HTI Halozyme Therapeutics, Inc. Buy 53,500 2.84 151,940
2006-09-14 HTI Halozyme Therapeutics, Inc. Buy 20,000 2.50 50,000
2006-09-15 HTI Halozyme Therapeutics, Inc. Buy 102,500 2.50 256,250
2006-09-13 CLDA Clinical Data Inc Buy 30,571 15.42 471,404
2006-09-11 HTI Halozyme Therapeutics, Inc. Buy 3,200 2.54 8,128
2006-09-12 HTI Halozyme Therapeutics, Inc. Buy 20,000 2.58 51,600
2006-09-13 HTI Halozyme Therapeutics, Inc. Buy 74,000 2.50 185,000
2006-09-06 HTI Halozyme Therapeutics, Inc. Buy 17,300 2.56 44,288
2006-09-08 HTI Halozyme Therapeutics, Inc. Buy 30,500 2.52 76,860
2006-09-07 HTI Halozyme Therapeutics, Inc. Buy 15,000 2.51 37,650
2006-09-06 CLDA Clinical Data Inc Buy 42,000 14.95 627,900
2006-08-29 HTI Halozyme Therapeutics, Inc. Buy 23,000 2.60 59,800
2006-08-28 CLDA Clinical Data Inc Buy 13,990 15.07 210,829
2006-08-29 CLDA Clinical Data Inc Buy 12,621 15.00 189,315
2006-08-25 CLDA Clinical Data Inc Buy 7,697 13.48 103,755
2006-08-28 HTI Halozyme Therapeutics, Inc. Buy 60,000 2.56 153,600
2006-08-25 HTI Halozyme Therapeutics, Inc. Buy 110,900 2.50 277,250
2006-08-22 HTI Halozyme Therapeutics, Inc. Buy 17,600 2.46 43,296
2006-08-23 HTI Halozyme Therapeutics, Inc. Buy 6,700 2.49 16,683
2006-08-22 CLDA Clinical Data Inc Buy 4,012 12.30 49,347
2006-08-24 CLDA Clinical Data Inc Buy 10,693 13.17 140,826
2006-08-23 CLDA Clinical Data Inc Buy 12,500 12.97 162,125
2006-08-24 HTI Halozyme Therapeutics, Inc. Buy 93,300 2.50 233,250
2006-08-21 HTI Halozyme Therapeutics, Inc. Buy 12,500 2.46 30,750
2006-08-18 HTI Halozyme Therapeutics, Inc. Buy 3,500 2.42 8,470
2006-08-17 HTI Halozyme Therapeutics, Inc. Buy 94,100 2.46 231,486
2006-05-18 CLDA Clinical Data Inc Buy 100,000 20.00 2,000,000
2006-05-18 CLDA Clinical Data Inc Buy 100,000 20.00 2,000,000
2005-09-01 NRPH New River Pharmaceuticals Inc Sale 11,919 41.74 497,510
2005-06-15 NRPH New River Pharmaceuticals Inc Sale 187,000 30.00 5,610,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kirk Randal J (Officer of Aquabounty Technologies, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month